Kevin Ess, Associate professor of Neurology and paediatrics was interviewed by AHCIM in London 2016 at the ATP1A3 symposium
“imagine a world where we are able to treat children with AHC before they show any symptoms”
The purpose of AHC International Media is to collect information about AHC and related disorders and make them visible for everyone.
Doctors, researchers and family can share information on this media and together we can help each other get closer to the goal of having an effective treatment for AHC.
AHCIM will continue to interview interested parties that have information on AHC or related disorders to share .
Sho Yano was interviewed by AHCIM in Washington, DC, August 2015
Sho Yano believes that ATP1A3 mutations are much more common than we realize
Some people have 1 or 2 episodes in a lifetime that is explained as infection, meningitis or something else and they never know that they actually have a mutation in ATP1A3
Dr. Sho Yano is an Asian-American prodigy with an estimated IQ of 200. His father is from Japan and his mother is from South Korea.
Dr. Yano showed signs of exceptional abilities at a very early age- he started reading at the age of 2, writing by the age of 3, composing music by age 5 and scored 1,500 out of 1,600 on SAT at the age of 8. In the following year, at the age of 9, he entered Loyola University of Chicago which made him the youngest person to get into college in the U.S., and three years later, he entered medical school to persuade his dream of becoming a doctor. And at the age of 21, he graduated from the University Of Chicago Pritzker School Of Medicine (MD), where he also received a PhD in molecular genetics and cell biology, and now, he is the youngest MD from University of Chicago and the second youngest MD in history.